What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.12%Below 5Y avg (2.38%)
Annual Rate
KRW 70.00Paid annual
Payout Ratio
43.4%Sustainable
Payback Period
93.6 yr
Last Ex-Dividend
Aug 28, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
1.21TKRW
874.82M · vs all stocks (USD)
Updated Sep 19, 2026
Trailing P/E
24.36x
vs Conglomerates peers
Updated Sep 19, 2026
Revenue (TTM)
6.78TKRW
4.88B · vs all stocks (USD)
Updated Sep 19, 2026
Profit Margin
1.76%
vs Conglomerates peers
Updated Sep 19, 2026
Beta
1.23x
vs all stocks
Updated Sep 19, 2026
52-Week Change
36.68%
vs all stocks
Updated Sep 19, 2026
Market Capitalization
1.21TKRW
874.82M · vs all stocks (USD)
Updated Sep 19, 2026
Enterprise Value
2.77TKRW
1.99B · vs all stocks (USD)
Updated Sep 19, 2026
Trailing P/E
24.36x
vs Conglomerates peers
Updated Sep 19, 2026
Forward P/E
17.15x
vs Conglomerates peers
Updated Sep 19, 2026
PEG Ratio
0.2704x
vs Conglomerates peers
Updated Sep 19, 2026
Price to Sales (TTM)
0.1791x
vs Conglomerates peers
Updated Sep 19, 2026
Price to Book (MRQ)
0.5533x
vs Conglomerates peers
Updated Sep 19, 2026
Enterprise to Revenue
0.4080x
vs Conglomerates peers
Updated Sep 19, 2026
Enterprise to EBITDA
11.49x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.64×.Updated Sep 19, 2026
Gross Margin
15.13%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 12.84%.Updated Sep 19, 2026
Profit Margin
1.76%
vs Conglomerates peers
Updated Sep 19, 2026
Operating Margin
1.72%
vs Conglomerates peers
Updated Sep 19, 2026
Return on Assets (TTM)
1.01%
vs Conglomerates peers
Updated Sep 19, 2026
Return on Equity (TTM)
5.43%
vs Conglomerates peers
Updated Sep 19, 2026
Revenue (TTM)
6.78TKRW
4.88B · vs all stocks (USD)
Updated Sep 19, 2026
Revenue per Share (TTM)
35.07KKRWUpdated Sep 19, 2026
Quarterly Revenue Growth
-4.70%
vs Conglomerates peers
Updated Sep 19, 2026
Gross Profit (TTM)
870.67BKRW
627.27M · vs all stocks (USD)
Updated Sep 19, 2026
EBITDA (TTM)
260.11BKRW
187.39M · vs all stocks (USD)
Updated Sep 19, 2026
Net Income (TTM)
111.67BKRW
80.45M · vs all stocks (USD)
Updated Sep 19, 2026
Quarterly Earnings Growth (YoY)
90.40%
vs Conglomerates peers
Updated Sep 19, 2026
Operating Cash Flow (TTM)
-28.37BKRW
-20.44M · vs all stocks (USD)
Updated Sep 19, 2026
Levered Free Cash Flow (TTM)
-38.93BKRW
-28.05M · vs all stocks (USD)
Updated Sep 19, 2026
Trailing Annual Dividend Rate
70.00KRWUpdated Sep 19, 2026
Trailing Annual Dividend Yield
1.12%
vs all stocks
Updated Sep 19, 2026
5-Year Average Dividend Yield
2.38%
vs all stocks
Updated Sep 19, 2026
Payout Ratio
43.40%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 27.24%.Updated Sep 19, 2026
Minority Interest (Equity)
1.87BKRWFY2025 · Dec 31, 2025
Revenue
6.75TKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
5.88TKRWFY2025 · Dec 31, 2025
Gross Profit
868.24BKRWFY2025 · Dec 31, 2025
Operating Income
86.29BKRW
62.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
61.12BKRWFY2025 · Dec 31, 2025
Income Tax Expense
1.76BKRWFY2025 · Dec 31, 2025
Net Income
49.98BKRWFY2025 · Dec 31, 2025
EBIT
125.24BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
265.80BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
340.61BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
30.86BKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
12.95BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
64.12BKRWFY2025 · Dec 31, 2025
Net Income from Continuing Operations
49.98BKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
-160.00MKRWFY2025 · Dec 31, 2025
Operating Cash Flow
50.02BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-18.97BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
448.42BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
49.98BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
-341.00MKRWFY2025 · Dec 31, 2025
Other Non-cash Items
52.53BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-97.82BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
45.66BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-68.99BKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-1.27BKRWFY2025 · Dec 31, 2025
Net Acquisitions
32.96BKRWFY2025 · Dec 31, 2025
Purchase of Investments
-18.14BKRWFY2025 · Dec 31, 2025
Sale of Investments
127.44BKRWFY2025 · Dec 31, 2025
Other Investing Activity
3.10BKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
76.37BKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
648.04BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-850.60BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-850.60BKRWFY2025 · Dec 31, 2025
Common Stock Repurchase
-5.00MKRWFY2025 · Dec 31, 2025
Common Dividends Paid
-48.51BKRWFY2025 · Dec 31, 2025
Other Financing Charges
-1.64BKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.10TKRWFY2025 · Dec 31, 2025
Shares Outstanding
193.95MSharesUpdated Sep 19, 2026
Float Shares
95.48MSharesUpdated Sep 19, 2026
% Held by Insiders
49.01%
vs all stocks
Updated Sep 19, 2026
% Held by Institutions
14.82%
vs all stocks
Updated Sep 19, 2026
Total Cash (MRQ)
396.33BKRW
285.54M · vs all stocks (USD)
Updated Sep 19, 2026
Total Cash per Share (MRQ)
2.04KKRWUpdated Sep 19, 2026
Total Debt (MRQ)
1.87TKRW
1.34B · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt to Equity (MRQ)
0.8507x
vs Conglomerates peers
Updated Sep 19, 2026
Current Ratio (MRQ)
1.01x
vs Conglomerates peers
Updated Sep 19, 2026
Book Value per Share (MRQ)
11.31KKRWUpdated Sep 19, 2026
Total Assets
5.04TKRW
3.63B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.83TKRWFY2025 · Dec 31, 2025
Total Liabilities
3.02TKRWFY2025 · Dec 31, 2025
Total Non-current Assets
3.21TKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.23TKRWFY2025 · Dec 31, 2025
Total Current Liabilities
1.78TKRWFY2025 · Dec 31, 2025
Cash
442.87BKRWFY2025 · Dec 31, 2025
Cash Equivalents
5.54BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
448.42BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
109.67BKRWFY2025 · Dec 31, 2025
Accounts Receivable
512.43BKRWFY2025 · Dec 31, 2025
Inventory
356.38BKRWFY2025 · Dec 31, 2025
Accounts Payable
682.86BKRWFY2025 · Dec 31, 2025
Short-term Debt
753.56BKRWFY2025 · Dec 31, 2025
Long-term Debt
1.09TKRWFY2025 · Dec 31, 2025
Common Stock (Book)
620.47BKRWFY2025 · Dec 31, 2025
Retained Earnings
756.48BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.03TKRW
1.46B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
144.12BKRWFY2025 · Dec 31, 2025
52-Week Low
4.28KKRWUpdated Sep 19, 2026
52-Week High
16.24KKRWUpdated Sep 19, 2026
52-Week Change
36.68%
vs all stocks
Updated Sep 19, 2026
Beta
1.23x
vs all stocks
Updated Sep 19, 2026
50-Day MA
7.17KKRWUpdated Sep 19, 2026
200-Day MA
6.69KKRWUpdated Sep 19, 2026
Avg 10-Day Volume
650.91KSharesUpdated Sep 19, 2026
Avg 30-Day Volume
918.54KSharesUpdated Sep 19, 2026
Diluted EPS (TTM)
257.00KRWUpdated Sep 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.